vimarsana.com

ஒழுங்குபடுத்தப்பட்டது சந்தைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Strides Pharma to pursue portfolio maximisation in regulated markets

Strides Pharma to pursue portfolio maximisation in regulated markets February 10, 2021 R Ananthanarayanan, Managing Director & CEO, Strides Pharma Sciences× To develop products across multiple therapeutics segments Strides Pharma Science Limited plans to pursue portfolio maximisation strategy across the regulated markets to unlock value. It is also exploring to develop a wide range of products across multiple therapeutics segments. “Further to the Stelis demerger, Strides will keep open the option of adding injectables to its portfolio to complement its oral solid and topicals business as part of the portfolio maximisation strategy and will retain 100 per cent of the economics for the business,” the company’s spokesperson told

Caplin Steriles partners with JAMP Pharma to produce 6 injectables for Canada

Caplin Steriles partners with JAMP Pharma to produce 6 injectables for Canada Premium (REUTERS) Caplin Steriles is a subsidiary of Caplin Point Share Via Read Full Story Caplin Point on Monday announced that its subsidiary Caplin Steriles Limited has partnered with JAMP Pharma Group to produce six injectable to be filed shortly in Canada. Some of these products have already been filed by Caplin Steriles in the USA. TRENDING STORIESSee All 1 min read Premium 2 min read Premium 2 min read Premium 1 min read Commenting on the transaction, Mr C. C. Paarthipan, Chairman of Caplin PointLaboratories Limited, said: We have targeted Canada as one of our key expansion areas in Regulated Markets and we are excited to work with ]AMP, one of the fastest growing companies in Canada.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.